688238 和元生物
按盤價 
6.710 +0.960 (+16.696%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.841 | -14.935 | -16.946 | -6.049 | 2.541 |
| 總資產報酬率 ROA (%) | -2.596 | -10.742 | -13.167 | -5.017 | 2.088 |
| 投入資產回報率 ROIC (%) | -2.861 | -12.064 | -14.951 | -5.585 | 2.302 | 邊際利潤分析 |
| 銷售毛利率 (%) | -23.847 | -14.521 | -37.808 | -6.374 | 44.411 |
| 營業利潤率 (%) | -105.342 | -86.948 | -125.106 | -75.900 | 14.318 |
| 息稅前利潤/營業總收入 (%) | -107.668 | -84.755 | -125.825 | -83.886 | 4.865 |
| 淨利潤/營業總收入 (%) | -104.994 | -87.715 | -129.834 | -62.408 | 13.476 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.261 | 96.283 | 89.823 | 100.112 | 85.566 |
| 價值變動淨收益/利潤總額(%) | 0.378 | -2.650 | -0.084 | 0.743 | 5.510 |
| 營業外收支淨額/利潤總額(%) | 0.000 | 0.138 | 0.696 | 0.101 | -0.201 | 償債能力分析 |
| 流動比率 (X) | 1.283 | 1.232 | 2.093 | 2.952 | 7.836 |
| 速動比率 (X) | 1.074 | 1.077 | 1.869 | 2.695 | 7.484 |
| 資產負債率 (%) | 32.069 | 32.684 | 23.862 | 20.938 | 13.009 |
| 帶息債務/全部投入資本 (%) | 20.427 | 19.781 | 9.167 | 6.420 | 1.050 |
| 股東權益/帶息債務 (%) | 363.277 | 377.804 | 942.869 | 1,398.744 | 9,037.552 |
| 股東權益/負債合計 (%) | 211.567 | 205.956 | 319.115 | 377.573 | 668.693 |
| 利息保障倍數 (X) | 46.267 | -36.633 | -793.204 | 10.606 | -0.516 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 168.710 | 115.405 | 106.803 | 129.204 | 65.895 |
| 存貨周轉天數 (天) | 105.197 | 83.888 | 81.377 | 121.037 | 121.920 |
| 備註： | 即時報價更新時間為 10/07/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
